Efferon
Entity

  • Efferon

    Created in 2016


  • Trend leader (A+)
    Existing signals make this entity one of the most dynamic startups

  • Social networks

    1,181

  • Activities

    deeptech healthtech

  • Entity types

    Startup

  • Location

    Hans-Gasser-Platz, 9500 Villach, Austria

    Villach

    Austria

  • Employees

    Scale: 51-200

    Estimated: 12

  • Engaged catalyst

    0
    0 0

  • Added in Motherbase

    3 months, 2 weeks ago
Description
  • Value proposition

    Next-generation hemoperfusion devices to treat sepsis and multiple organ failure syndrome. Company's flagship product, Efferon LPS single-use hemoperfusion device is granted CE mark approval under EU MDR.

    Clinically validated approach, over 10.000 treated critical patients.

    Founded in 2016 to translate the most advanced polymeric adsorbent technology into routine clinical practice and to fight morbid diseases.

  • Systemic Inflammation Therapy Platform

    Multimodal hemoadsorption technology for sepsis, septic shock, and cytokine release syndrome. CE-marked in the European Union.

    • https://efferon.com/
Catalyst interactions
Catalyst Type Tweets Articles
No interactions
Social network dynamics
Similar entities
BETA
Last news
Show all articles